Novo Nordisk to acquire Inversago Pharma and its obesity drug development for $1.07B
Novo Nordisk, which operates its U.S. headquarters out of Plainsboro, on Thursday announced it will acquire ...
Read more
Novo Nordisk, which operates its U.S. headquarters out of Plainsboro, on Thursday announced it will acquire ...
Read more